Literature DB >> 6311786

Multiple dose pharmacokinetics of ketoconazole and their effects on antipyrine kinetics in man.

T K Daneshmend, D W Warnock, M D Ene, E M Johnson, G Parker, M D Richardson, C J Roberts.   

Abstract

Ketoconazole 200 mg was given twice daily for five days to eight subjects. The serum pharmacokinetics were examined with the first dose on day 1 and with the ninth dose on day 5. The serum half life of ketoconazole was 74.8 +/- 13.9 min (mean +/- S.D.) on day 1, and 155.9 +/- 32.7 min on day 5. On day 1 the area under the serum concentration time curve was 626.9 +/- 230.1 mg/l.min, and 1441 +/- 897.3 mg/l.min on day 5. Antipyrine kinetics were determined before and after the course of ketoconazole. There was no significant change in the clearance and half life of antipyrine. Ketoconazole in the doses used in this study does not appear to alter hepatic microsomal enzyme activity in man. The increased ketoconazole half life and area under the serum concentration time curve on day 5 were in part caused by food. Other mechanisms for these changes such as saturation of a tissue compartment or a change in the elimination of ketoconazole during chronic dosing, may also be responsible.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311786     DOI: 10.1093/jac/12.2.185

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  13 in total

Review 1.  Pharmacokinetic drug interactions with cyclosporin (Part II).

Authors:  G C Yee; T R McGuire
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 2.  Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.

Authors:  K Venkatakrishnan; L L von Moltke; D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  2000-02       Impact factor: 6.447

3.  A Bayesian meta-analysis on published sample mean and variance pharmacokinetic data with application to drug-drug interaction prediction.

Authors:  Menggang Yu; Seongho Kim; Zhiping Wang; Stephen Hall; Lang Li
Journal:  J Biopharm Stat       Date:  2008       Impact factor: 1.051

4.  Pharmacokinetics of the cyclosporine-ketoconazole interaction in dogs.

Authors:  A D'mello; R Venkataramanan; M Satake; S Todo; S Takaya; R J Ptachcinski; G J Burckart; T E Starzl
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1989-06

5.  The pharmacokinetics of ketoconazole after chronic administration in adults.

Authors:  N R Badcock; F D Bartholomeusz; D B Frewin; L N Sansom; J G Reid
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

6.  CSM update: adverse drug reactions and the liver.

Authors:  G Lake-Bakaar; H A Cameron
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-14

7.  A phase I clinical study of high dose ketoconazole plus weekly docetaxel for metastatic castration resistant prostate cancer.

Authors:  William D Figg; Sukyung Woo; Wenhui Zhu; Xiaohong Chen; A Seun Ajiboye; Seth M Steinberg; Douglas K Price; John J Wright; Howard L Parnes; Philip M Arlen; James L Gulley; William L Dahut
Journal:  J Urol       Date:  2010-06       Impact factor: 7.450

8.  Influence of food on the pharmacokinetics of ketoconazole.

Authors:  T K Daneshmend; D W Warnock; M D Ene; E M Johnson; M R Potten; M D Richardson; P J Williamson
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

9.  Systemic absorption of ketoconazole from vaginal pessaries.

Authors:  M D Ene; P J Williamson; T K Daneshmend; N R Blatchford
Journal:  Br J Clin Pharmacol       Date:  1984-02       Impact factor: 4.335

10.  Pharmacokinetics and dose proportionality of ketoconazole in normal volunteers.

Authors:  Y C Huang; J L Colaizzi; R H Bierman; R Woestenborghs; J Heykants
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.